Management of Urinary Incontinence After Back Surgery
Begin with pelvic floor muscle training (PFMT) immediately as first-line treatment, and assess the specific type of incontinence (stress, urgency, or mixed) to guide additional interventions. 1
Initial Assessment
Determine the type and severity of incontinence through focused evaluation:
- Stress incontinence: Leakage with coughing, sneezing, or physical activity due to sphincter dysfunction 1
- Urgency incontinence: Involuntary loss with sudden compelling urge to void 1
- Mixed incontinence: Combination of both stress and urgency components 1
- Overflow incontinence: May occur if denervation happened during surgery, requiring catheterization 1
Evaluate the timeline since surgery, frequency of episodes, number of pads used daily, and impact on quality of life to determine treatment urgency. 1
First-Line Treatment: Pelvic Floor Muscle Training
Start PFMT immediately for all types of post-surgical incontinence, as it provides up to 70% improvement in symptoms and is most effective when supervised by a specialist physiotherapist or continence nurse. 1, 2
- PFMT involves voluntary contraction of pelvic floor muscles (Kegel exercises) 1
- Supervised programs for at least 3 months are superior to unsupervised or leaflet-based care 2
- Consider adding biofeedback using vaginal EMG to provide visual feedback on proper muscle contraction 1, 3
- Continue conservative management for at least 6 months before considering other interventions 4, 5
Important caveat: If denervation occurred during back surgery, Kegel exercises may not be effective and catheterization may be required. 1
Type-Specific Management
For Stress Incontinence Post-Surgery
- Primary treatment: PFMT as described above 1, 2
- Avoid systemic pharmacologic therapy, as it has not been shown effective for stress incontinence 1
- Consider referral to urology if symptoms persist beyond 6-12 months despite optimal conservative therapy 1, 4
For Urgency Incontinence Post-Surgery
Implement bladder training as the cornerstone intervention, which involves behavioral therapy to extend time between voiding. 1
If bladder training fails after adequate trial:
- First-line medication: Antimuscarinic drugs (anticholinergics) 1
- Specific agent recommendations: Tolterodine or solifenacin preferred over oxybutynin due to better tolerability 1, 5
- Limit caffeine and fluid intake; avoid bladder irritants like citrus and tomatoes 1
For Mixed Incontinence Post-Surgery
Combine PFMT with bladder training, as this combination improves both continence rates and quality of life. 1
Add pharmacologic therapy only if urgency component persists despite behavioral interventions. 1
Pharmacologic Considerations
When medications are necessary for urgency symptoms:
- Tolterodine: Better adverse effect profile than oxybutynin 1
- Solifenacin: Effective alternative with number needed to benefit of 9 5
- Avoid oxybutynin as first-line due to high adverse effect burden 1, 5
Critical warning: Many patients discontinue pharmacologic treatment due to adverse effects, so base medication choice on tolerability, adverse effect profile, ease of use, and cost. 1
Referral Indications
Refer to rehabilitation and pain management services as needed for comprehensive care. 1
Refer to urology for:
- Prolonged urinary retention postoperatively 1
- Persistent hematuria (requires cystoscopy to investigate secondary causes) 1
- Severe incontinence not improving after 6 months of conservative therapy 4, 5
- Hypocontractile bladder requiring specialized catheterization management 1
Common Pitfalls to Avoid
- Do not rush to surgical or invasive interventions before completing at least 6 months of conservative therapy, as most patients improve significantly within the first year 4, 5
- Do not prescribe Kegel exercises if denervation occurred during surgery, as they will be ineffective 1
- Do not use systemic pharmacologic therapy for pure stress incontinence, as it lacks efficacy 1
- Do not overlook the urgency component in mixed incontinence, which requires specific antimuscarinic treatment 1, 5